Gross pathology photograph of the liver surface from a case of alcoholic liver disease. The image shows diffuse micronodularity of the parenchyma with a coarse, irregular texture and reddish-brown coloration. Nodularity is predominantly micronodular (<3 mm) due to widespread fibrosis, with occasional larger regenerative nodules that may reflect hepatocyte regeneration during abstinence. The hepatic surface is nodular and uneven, indicating bridging fibrosis and loss of normal lobular architecture. A centimeter-scale ruler is present for size reference, confirming small nodules and expanded fibrous septa. This macroscopic pattern is characteristic of cirrhosis in advanced alcoholic liver disease, where irreversible architectural remodeling yields a nodular, firm liver with altered contour. Pathological significance includes portal hypertension risk, impaired synthetic function, and increased hepatocellular carcinoma risk. Clinically, this appearance correlates with long-standing alcohol exposure, potential ascites, and abnormal liver function tests. The image serves as an educational reference for hepatology, pathology, and medical education, illustrating end-stage liver disease, nodular regeneration, and fibrosis. Differential considerations include cirrhosis from other etiologies (viral hepatitis, biliary disease, nonalcoholic fatty liver disease) and variation in nodularity with disease stage and abstinence. This photograph aids gross-pathology correlation with histology and radiology in teaching cases and supports case-based learning.

This clinical photograph displays a macroscopic view of a human liver specimen exhibiting advanced alcoholic cirrhosis. The organ demonstrates a characteristic micronodular surface, where the normally smooth capsule is replaced by a diffuse, granular texture. These numerous small, rounded protrusions represent regenerative nodules of hepatocytes surrounded by dense fibrotic septa. The liver color is predominantly reddish-brown with yellowish-tan areas, likely reflecting steatosis (fatty change) and variation in tissue density. Bright, fragmented light reflexes on the surface highlight the irregular, cobweb-like topography and uneven capsule tension typical of end-stage chronic liver disease. The specimen illustrates the pathological progression from chronic alcohol-induced injury to extensive fibrosis and architectural distortion, which are key diagnostic features of cirrhosis in hepatology and pathology education.

This is a gross pathology photograph of a human liver showing diffuse micronodular cirrhosis with nodules smaller than 3 mm on the surface, consistent with alcoholic liver disease. The organ appears enlarged and firm, with a coarse, irregular exterior and a nodular regenerative pattern that distorts normal lobular architecture. Coloration is mottled brownish-red, reflecting parenchymal degeneration and fibrotic remodeling; the capsule surface is intact but irregular. The microscopic correlate would reveal widespread hepatic fibrosis with fibrous septa and numerous tiny regenerative nodules; histology would show steatosis, ballooning degeneration, inflammation, and eventual cirrhotic architecture. The described micronodularity (<3 mm) indicates advanced fibrosis rather than macro-nodular cirrhosis, and underscores the progression from steatosis to steatohepatitis to cirrhosis in long-term alcohol exposure. Clinically, this morphology signals portal hypertension risk, reduced synthetic function, and potential progression to hepatic failure; timely management includes alcohol cessation, nutritional support, surveillance for varices, and evaluation for liver transplantation in end-stage disease. This image is informative for education on liver gross anatomy, correlation with histopathology, and teaching about alcohol-related liver disease staging. It is appropriate for pathology, hepatology, and radiology-pathology correlation. Note the dominant nodularity and preserved capsule, features commonly seen in alcoholic micronodular cirrhosis for teaching and research applications.

This diagnostic B-mode transabdominal ultrasound image displays the right lobe of the liver in a patient with Non-Alcoholic Fatty Liver Disease (NAFLD) progressing to cirrhosis. Key sonographic features include a markedly nodular and irregular liver surface, which is a pathognomonic indicator of advanced cirrhosis. The liver parenchyma exhibits an inhomogeneous, coarse echotexture with increased echogenicity relative to normal tissue. An anechoic layer of perihepatic ascites is visible between the abdominal wall and the liver capsule, enhancing the visualization of the surface nodularity. Within the right lobe, a discrete, hypoechoic focal lesion is identified and demarcated with yellow measurement calipers (labeled 1 and 2), representing a finding highly suspicious for hepatocellular carcinoma (HCC) in the clinical context of cirrhosis. This image serves as an educational tool for identifying the complications of chronic liver disease, specifically the morphological transition from steatosis to cirrhosis and secondary malignancy.

This is a liver biopsy histology image prepared for light microscopy, stained with hematoxylin and eosin (H&E). The primary subject is hepatocytes within the hepatic parenchyma showing features of alcoholic steatohepatitis. Macrovesicular steatosis is evident, with numerous large fat vesicles displacing the cytoplasm. More striking are ballooned hepatocytes, enlarged cells with pale, cytoplasmic clearing and disrupted cytoskeletal architecture. Within several ballooned cells, Mallory-Denk bodies (Mallory hyaline) appear as irregular eosinophilic, hyaline inclusions. The nuclear morphology is variably preserved, with occasionally pyknotic or shrunken nuclei in chronically damaged hepatocytes. The overall cellular morphology indicates hepatocellular injury with cytoskeletal disruption and intracellular inclusions consistent with steatohepatitis. Notably, CK8/18 immunostaining would reveal reduced or absent intermediate filament networks in ballooned hepatocytes, a feature that helps distinguish steatohepatitic ballooning from non-steatohepatitic ballooning seen in viral hepatitis where CK8/18 loss is less pronounced. In alcoholic liver disease, Mallory-Denk bodies and cytoplasmic clearing correlate with ongoing inflammation and progressive fibrosis risk, informing diagnostic significance and clinical management. This image is valuable for education on histologic differentiation between alcoholic steatohepatitis and other causes of hepatocellular ballooning, and for teaching pathology students about steatosis-related cytoskeletal disruption. Correlation with alcohol history and fibrosis staging enhances clinical decision making.

Light microscopy of a formalin‑fixed, paraffin‑embedded liver biopsy stained with Hematoxylin and Eosin demonstrates features of alcoholic liver disease with residual steatohepatitis and cirrhosis. Macrovesicular steatosis is evident in hepatocytes, with hepatocellular ballooning and intracellular Mallory‑Denk bodies representing damaged cytokeratin aggregates. Intermixed neutrophils and lymphocytes comprise the inflammatory infiltrate, including CD4+ and CD8+ T‑cell subsets, consistent with active inflammatory activity. Pericellular, “chicken‑wire” fibrosis surrounds hepatocytes and extends into bridging fibrosis, reflecting advanced architectural distortion and nodularity characteristic of cirrhosis. Lobular disarray and hepatocyte loss contribute to disrupted lobular architecture, while residual portal and central zones display inflammatory activity. These histologic features—steatosis, ballooning degeneration, Mallory‑Denk inclusions, lobular inflammation, and pericellular fibrosis—define a spectrum of steatohepatitis within alcoholic liver disease and correlate with progressive hepatic injury. Clinically, the pattern supports a history of chronic alcohol exposure and bears significance for prognosis, risk of portal hypertension, and hepatocellular carcinoma surveillance. Differential considerations include nonalcoholic steatohepatitis and drug‑induced liver injury; however, Mallory‑Denk bodies and neutrophil predominance strongly favor alcohol‑related injury. Correlate with laboratory data (AST>ALT, elevated GGT) and clinical history for comprehensive assessment. This microcosm illustrates bridging fibrosis, residual cirrhotic nodules, and preservation of some lobular units, guiding staging, prognosis, and therapy decisions in alcoholic liver disease management.

This light microscopy hematoxylin and eosin (H&E) stained liver biopsy section demonstrates alcoholic steatohepatitis with classic macrovesicular steatosis, strongest in acinar zone 3 (centrilobular/perivenular region). Large intracellular lipid droplets displace hepatocyte nuclei to the cell margins, producing a foamy cytoplasm. Hepatocellular ballooning is apparent, with occasional Mallory-Denk bodies representing cytoskeletal inclusions. Neutrophilic and lymphocytic inflammatory infiltrates interrupt hepatocyte plates around damaged cells. Pericellular (chicken-wire) fibrosis encircles hepatocytes, indicating early fibrotic remodeling that may progress to bridging fibrosis and cirrhosis. In early disease, steatosis predominates in centrilobular zones whereas periportal hepatocytes show ballooning with little lipid accumulation. The histologic constellation—macrovesicular steatosis, ballooned hepatocytes, Mallory-Denk bodies, and mixed inflammatory infiltrate with pericellular fibrosis—is highly suggestive of alcoholic hepatitis. Differential considerations include nonalcoholic steatohepatitis when ethanol exposure is uncertain; however, the distribution and cytoplasmic features support alcohol-related injury. Clinically, these findings correlate with substantial alcohol use and risk of progression to cirrhosis and hepatic failure. The image is valuable for education, biopsy interpretation, and research on hepatocellular injury, steatosis patterns, and fibrotic remodeling in alcoholic liver disease.

This side-by-side comparison displays two abdominal ultrasound images (B-mode) in the longitudinal plane, illustrating the diagnostic features of nonalcoholic fatty liver disease (NAFLD). Image (a) represents a normal liver, showing a solid, homogeneous echo texture with an echogenicity similar to or slightly higher than the adjacent renal cortex. Vascular structures are well-defined with clear borders, and there is minimal acoustic attenuation, allowing for distinct visualization of deep posterior structures and the diaphragm. Image (b) demonstrates hepatic steatosis (fatty liver). Key diagnostic findings include diffusely increased hepatic echogenicity (the 'bright liver' sign), which creates a significant contrast discrepancy with the renal parenchyma. Furthermore, there is a noticeable blurring of intrahepatic vascular margins and increased acoustic attenuation, resulting in poor visualization of the deeper liver parenchyma and posterior diaphragm. These findings are characteristic of moderate to severe steatosis in the context of NAFLD.

Two B-mode ultrasound images (A and B) of the liver in a 41-year-old male with nonalcoholic fatty liver disease (NAFLD). Image A shows a longitudinal view of the right upper quadrant, comparing the echogenicity of the hepatic parenchyma to the right renal cortex; the liver appears isoechoic to the kidney, which is a finding typically interpreted as no ultrasound-evident fatty liver. Image B provides a broader view of the hepatic anatomy, demonstrating clear visualization of the hepatic vessel walls and the curvilinear, hyperechoic diaphragm. There is an absence of visual indicators for chronic liver disease or cirrhosis, such as surface nodularity or coarse parenchymal texture. These images illustrate a case of discordant findings where B-mode ultrasound failed to detect hepatic steatosis that was otherwise confirmed by a high MRI proton density fat fraction (MRI-PDFF) of 9.1%. This case serves as an educational example of the sensitivity limitations of qualitative B-mode ultrasonography in detecting mild steatosis.

This diagnostic comparison chart features synthetic B-mode liver ultrasound images alongside SHAP (Shapley Additive Explanations) heatmaps, illustrating the classification of Nonalcoholic Fatty Liver Disease (NAFLD). The top row showcases 'unhealthy' cases characterized by increased liver echogenicity (hyperechoic) relative to the renal cortex and blurred hepatic vein boundaries, indicative of hepatic steatosis. The bottom row displays 'healthy' cases with iso-echogenic patterns between the liver and kidney and well-defined vascular structures. Each ultrasound image is paired with a SHAP value heatmap where red pixels indicate positive contributions toward an 'unhealthy' classification (concentrated in the liver and kidney cortex of fatty livers) and blue pixels indicate features contributing to a 'healthy' classification (focused on clear diaphragmatic and portal vein boundaries). Green dotted rectangles highlight specific regions of interest used by the CNN classifier to differentiate between normal and diseased liver states. This visual aid is designed for advanced medical imaging informatics and radiology education regarding AI-driven diagnostic features in hepatology.

A comparative diagnostic image panel demonstrating Real-time Tissue Elastography (RTE) of the liver across four clinical stages: Normal, Mild Nonalcoholic Fatty Liver Disease (NAFLD), Moderate NAFLD, and Severe NAFLD. Each quadrant displays a B-mode ultrasound image of the liver parenchyma paired with a corresponding color-coded elastogram overlay and a histogram of strain distribution. The color scale indicates tissue stiffness, ranging from blue (hard) to red (soft). Progression from normal to severe NAFLD shows an increase in tissue heterogeneity and a visible shift in the histogram morphology. Quantitative parameters below each image track the evolution of disease, specifically showing an increasing '%AREA' (17.30% to 48.32%) and a decreasing 'MEAN' elasticity value (110.0 to 77.9), alongside increasing standard deviation (SD) values. This visual comparison illustrates the use of strain elastography to non-invasively assess and stage liver steatosis and fibrosis, providing critical diagnostic markers for metabolic liver disease management.

This pathophysiology diagram illustrates the proposed metabolic mechanisms underlying the reversal of Non-Alcoholic Fatty Liver Disease (NAFLD) and insulin resistance following Laparoscopic Sleeve Gastrectomy (SG). The upper section shows a clinical progression from an obese silhouette to a post-surgical weight-loss state. The lower section details cellular signaling pathways in a hepatocyte. Key features include: 1) Insulin receptor activation leading to Akt phosphorylation. 2) Downstream signaling where activated Akt phosphorylates GSK3αβ, resulting in increased glycogen deposits, and FoxO1, leading to nuclear exclusion and decreased gluconeogenesis. 3) An AMPK-mediated pathway where AMPK phosphorylates PLIN2 on lipid droplets (LD). This phosphorylation facilitates PLIN2 binding to LAMP2A, initiating Chaperone-Mediated Autophagy (CMA) within a lysosome. This mechanism demonstrates how reduced caloric intake post-SG enhances lipid catabolism and improves insulin sensitivity. The diagram is a high-level educational resource for endocrinology and gastroenterology, focusing on the interplay between bariatric surgery, AMPK activation, and hepatic metabolic regulation.

This pathophysiology diagram illustrates the suggestive molecular mechanism linking the FADS2 gene SNP rs174575 (G allele) to insulin resistance. The pathway begins with the FADS2 gene and the highlighted rs174575 variant, which leads to decreased polyunsaturated fatty acid (PUFA) metabolism. This reduction results in lower levels of biological ligands, specifically PUFAs, leukotrienes, and prostaglandins. These ligands normally bind to the Peroxisome Proliferator-Activated Receptor-gamma (PPAR-γ). In this model, altered ligand availability leads to diminished PPAR-γ activity. The diagram shows the PPAR-γ/RXR heterodimer complex bound to the Peroxisome Proliferator Response Element (PPRE) on a DNA sequence. The downstream functional consequences of decreased PPAR-γ activity are listed as reduced insulin sensitivity, decreased glucose uptake, and decreased lipid lowering. This sequence culminates in the development of insulin resistance, represented as a final starburst outcome. The illustration utilizes standard biochemical symbols, including a DNA double helix, geometric shapes for proteins (RXR, PPAR-γ), and flow arrows to indicate regulatory relationships in a cellular signaling context relevant to metabolic syndrome and Type 2 Diabetes Mellitus.

This medical infographic illustrates the pathophysiology and diagnostic interrelationships of non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome. The diagram is organized into four primary domains: clinical pathology, metabolic indicators, insulin resistance, and diagnostic imaging. At the top, a pink cloud representing insulin resistance (labeled HOMA_IR) connects via directional arrows to NAFLD (depicted as a stylized liver illustration) and to a blue panel of 'Metabolic factors'. These factors include clinical and laboratory parameters such as BMI, waist circumference (WC), blood pressure (SBP/DBP), lipid profiles (TG, HDL-C, LDL-C, TCHO), glycemic markers (FPG), and liver enzymes (ALT). The lower-left portion features a diagnostic B-mode ultrasound image of the liver showing a granular echotexture characteristic of hepatic steatosis. This imaging modality is linked to an 'Ultrasound quantitative diagnostic index' (QDI), which focuses on three key acoustic parameters: Backscatter, Echotexture, and Attenuation. A bidirectional arrow between the QDI parameters and the metabolic factors highlights the correlation between quantitative imaging biomarkers and the patient's systemic metabolic state, emphasizing the role of ultrasound in grading NAFLD severity and monitoring metabolic disarrangement.